Cargando…
[Corrigendum] Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation
Autores principales: | Wang, Long, Lu, Wei-Guang, Shi, Jun, Zhang, Hong-Yang, Xu, Xiao-Long, Gao, Bo, Huang, Qiang, Li, Xiao-Jie, Hu, Ya-Qian, Jie, Qiang, Luo, Zhuo-Jing, Yang, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433719/ https://www.ncbi.nlm.nih.gov/pubmed/37539751 http://dx.doi.org/10.3892/mmr.2023.13061 |
Ejemplares similares
-
Tetramethylpyrazine in Chinese baijiu: Presence, analysis, formation, and regulation
por: Shi, Xiaoshan, et al.
Publicado: (2022) -
Corrigendum to “Osteogenic Differentiation of hDPSCs on Biogenic Bone Apatite Thin Films”
por: Bianchi, Michele, et al.
Publicado: (2017) -
Corrigendum to “The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast”
por: Li, Yangyang, et al.
Publicado: (2021) -
GPR120: A bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs
por: Gao, Bo, et al.
Publicado: (2015) -
Corrigendum to “High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer”
por: Yang, Long, et al.
Publicado: (2019)